MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 169 filers reported holding MEDICINES CO in Q2 2013. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $22,541,000 | +140.6% | 265,373 | +41.6% | 0.14% | +122.2% |
| Q3 2019 | $9,369,000 | +67.1% | 187,373 | +21.9% | 0.06% | +40.0% |
| Q2 2019 | $5,606,000 | +231.9% | 153,713 | +154.4% | 0.04% | +200.0% |
| Q1 2019 | $1,689,000 | +53.1% | 60,413 | +4.9% | 0.02% | +66.7% |
| Q4 2018 | $1,103,000 | -18.8% | 57,613 | +26.9% | 0.01% | -10.0% |
| Q3 2018 | $1,358,000 | -11.3% | 45,413 | +8.9% | 0.01% | 0.0% |
| Q2 2018 | $1,531,000 | +11.4% | 41,717 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $1,374,000 | +24.7% | 41,717 | +3.5% | 0.01% | +42.9% |
| Q4 2017 | $1,102,000 | -26.2% | 40,317 | 0.0% | 0.01% | +16.7% |
| Q3 2017 | $1,493,000 | +6.6% | 40,317 | +9.5% | 0.01% | -50.0% |
| Q2 2017 | $1,400,000 | -43.1% | 36,826 | -26.8% | 0.01% | -45.5% |
| Q1 2017 | $2,461,000 | +48.2% | 50,326 | +2.9% | 0.02% | +37.5% |
| Q4 2016 | $1,661,000 | -10.0% | 48,926 | 0.0% | 0.02% | -15.8% |
| Q3 2016 | $1,846,000 | +12.2% | 48,926 | 0.0% | 0.02% | +5.6% |
| Q2 2016 | $1,645,000 | +5.9% | 48,926 | 0.0% | 0.02% | +5.9% |
| Q1 2016 | $1,554,000 | -14.9% | 48,926 | 0.0% | 0.02% | +13.3% |
| Q4 2015 | $1,827,000 | -34.5% | 48,926 | -33.5% | 0.02% | -40.0% |
| Q3 2015 | $2,791,000 | -4.7% | 73,526 | -28.1% | 0.02% | +19.0% |
| Q2 2015 | $2,928,000 | -15.3% | 102,326 | -17.1% | 0.02% | -19.2% |
| Q1 2015 | $3,458,000 | +1.6% | 123,426 | +0.3% | 0.03% | +18.2% |
| Q4 2014 | $3,405,000 | +25.1% | 123,040 | +0.9% | 0.02% | +22.2% |
| Q3 2014 | $2,722,000 | -34.4% | 121,940 | -14.6% | 0.02% | -28.0% |
| Q2 2014 | $4,148,000 | +11.8% | 142,740 | +9.4% | 0.02% | +4.2% |
| Q1 2014 | $3,709,000 | -38.3% | 130,500 | -16.1% | 0.02% | -35.1% |
| Q4 2013 | $6,009,000 | +19.3% | 155,600 | +3.5% | 0.04% | +19.4% |
| Q3 2013 | $5,038,000 | +54.8% | 150,300 | +42.1% | 0.03% | +24.0% |
| Q2 2013 | $3,254,000 | – | 105,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,778,742 | $138,680,000 | 22.51% |
| Sarissa Capital Management LP | 1,922,000 | $70,537,000 | 14.14% |
| Antipodean Advisors LLC | 165,500 | $6,074,000 | 7.66% |
| Boxer Capital, LLC | 1,250,000 | $45,875,000 | 5.19% |
| BRIDGER MANAGEMENT, LLC | 2,604,965 | $95,602,000 | 5.18% |
| Slate Path Capital LP | 1,730,000 | $63,491,000 | 4.80% |
| HighVista Strategies LLC | 268,240 | $9,844,000 | 4.44% |
| Camber Capital Management LP | 2,000,000 | $73,400,000 | 2.82% |
| Lion Point Capital, LP | 727,205 | $26,688,000 | 2.40% |
| THREE BAYS CAPITAL LP | 1,360,560 | $49,933,000 | 1.94% |